|
|
Blood, 1 March 2005, Vol. 105, No. 5, pp. 1977-1985.
Prepublished online as a Blood First Edition Paper on November 2, 2004; DOI 10.1182/blood-2004-08-3308.
Previous Article | Next Article 
Submitted August 25, 2004
Accepted October 24, 2004
Thrombin induces endocytosis of endoglin and type-II TGF- receptor and downregulation of TGF- signaling in endothelial cells
Hua Tang*, Brad Low, Stacey A Rutherford, and Qin Hao
Department of Biochemistry, The University of Texas Health Center at Tyler, Tyler, TX, USA
* Corresponding author; email: hua.tang{at}uthct.edu.
Thrombin activates protease-activated receptor 1 (PAR1) on endothelial cells (ECs) and is critical for angiogenesis and vascular development. However, the mechanism underlying the proangiogenic effect of thrombin has not been elucidated yet. Here, we report the discovery of a novel functional link between thrombin-PAR1 and transforming growth factor- (TGF- ) signaling pathways. We showed that thrombin via PAR1 induced the internalization of endoglin and type-II TGF- receptor (T RII) but not type-I receptors in human ECs. This effect was mediated by protein kinase C- (PKC- ) since specific inhibition of PKC- caused an aggregation of endoglin or T RII on cell surface and blocked their internalization by thrombin. Furthermore, acute and long-term pretreatment of ECs with thrombin or PAR1 peptide agonist suppressed the TGF- -induced serine phosphorylation of Smad2, a critical mediator of TGF- signaling. Moreover, activation of PAR1 led to a profound and spread cytosolic clustering formation of Smad2/3 and markedly prevented Smad2/3 nuclear translocation evoked by TGF- 1. Since TGF- plays a crucial role in the resolution phase of angiogenesis, the downregulation of TGF- signaling by thrombin-PAR1 pathway may provide a new insight into the mechanism of the proangiogenic effect of thrombin.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. K. Mandal, U. R. Pendurthi, and L. V. M. Rao
Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling
Blood,
July 1, 2007;
110(1):
161 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. I. Koleva, B. A. Conley, D. Romero, K. S. Riley, J. A. Marto, A. Lux, and C. P. H. Vary
Endoglin Structure and Function: DETERMINANTS OF ENDOGLIN PHOSPHORYLATION BY TRANSFORMING GROWTH FACTOR-beta RECEPTORS
J. Biol. Chem.,
September 1, 2006;
281(35):
25110 - 25123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Syeda, J. Grosjean, R. A. Houliston, R. J. Keogh, T. D. Carter, E. Paleolog, and C. P. D. Wheeler-Jones
Cyclooxygenase-2 Induction and Prostacyclin Release by Protease-activated Receptors in Endothelial Cells Require Cooperation between Mitogen-activated Protein Kinase and NF-{kappa}B Pathways
J. Biol. Chem.,
April 28, 2006;
281(17):
11792 - 11804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zhang, X. Liu, J. G. Cogan, M. D. Fuerst, J. A. Polikandriotis, R. J. Kelm Jr., and A. R. Strauch
YB-1 Coordinates Vascular Smooth Muscle {alpha}-Actin Gene Activation by Transforming Growth Factor {beta}1 and Thrombin during Differentiation of Human Pulmonary Myofibroblasts
Mol. Biol. Cell,
October 1, 2005;
16(10):
4931 - 4940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Belting, J. Ahamed, and W. Ruf
Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer
Arterioscler Thromb Vasc Biol,
August 1, 2005;
25(8):
1545 - 1550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tang, Q. Hao, S. A. Rutherford, B. Low, and Z. J. Zhao
Inactivation of Src Family Tyrosine Kinases by Reactive Oxygen Species in Vivo
J. Biol. Chem.,
June 24, 2005;
280(25):
23918 - 23925.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|